PHARMA

PHARMA

Pharmaceutical Hydrogenation Membrane in Italy

Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. Italy's hydrogen strategy targets industrial decarbonization across its chemical, refining, and steel sectors concentrated in Lombardy and Southern Italy.

Market Context

Italy

Policy

National Hydrogen Strategy

H₂ Target

5 GW electrolyser capacity by 2030

1

Cities

4

Industries

Ultra-Clean Hydrogen Source

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

GMP-Compatible On-Site Generation

On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.

Batch-Flexible Operation

Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.

Pharmaceutical Hydrogenation in Italy’s Hydrogen Market

Italy's hydrogen strategy targets industrial decarbonization across its chemical, refining, and steel sectors concentrated in Lombardy and Southern Italy. With significant solar resources in the south and industrial demand in the north, Italy is pursuing both green and blue hydrogen pathways.

IONZERA provides Italian industrial hydrogen projects with a high-performance membrane at competitive pricing, enabling more cost-effective electrolysis for the country's decarbonization goals.

SteelRefiningChemical ProcessingSolar-to-H2
3x

Lower Resistance

20%

Thinner Profile

PERFORMANCE ADVANTAGE

Why IONZERA for Pharmaceutical Hydrogenation in Italy

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

Shipping & Logistics

Air freight from India in 5-7 business days via Milan hub.

Area Resistance

3x LOWER
Area Specific Resistance ComparisonIONZERA0.09-0.1 Ω·cm²Zirfon0.30 Ω·cm²00.10.20.3 Ω·cm²~3x Lower

Thickness

20% THINNER
Membrane Thickness ComparisonIONZERA350-410 μmZirfon500 μm500 μm scale20-30%thinnerThinner membrane = More compact stacks= Higher power density

Pharmaceutical Hydrogenation Membrane in Italy Cities

Frequently Asked Questions

Why choose IONZERA for pharmaceutical hydrogenation in Italy?

IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in Italy. IONZERA provides Italian industrial hydrogen projects with a high-performance membrane at competitive pricing, enabling more cost-effective electrolysis for the country's decarbonization goals.

Is IONZERA suitable for Italian steel decarbonization projects?

Yes. IONZERA membranes are designed for high-efficiency hydrogen production via alkaline electrolysis, directly supporting hydrogen-based DRI steelmaking processes being adopted by Italian steel producers.

How is IONZERA shipped to Italy?

Air freight from Bengaluru to Milan in 5-7 business days. Volume orders can be shipped via sea freight with 4-6 week transit time.

Ready to Start

Request Pharmaceutical Hydrogenation Samples for Italy

Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for Italy-based projects.

Request Sample